Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial

Tovorafenib demonstrated anti-tumor activity in relapsed/refractory BRAF-altered OPG across radiological assessment criteria and was generally well tolerated. Importantly, vision remained stable or improved in most patients.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2024-12-19
DOI
https://doi.org/10.1093/neuonc/noae274
Citations
8
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
3.50

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial

Geoffrey McCowage, Daniel Landi, Darren Hargrave, Nicholas G. Gottardo et al.
8 citations
Neuro-Oncology
Glioma Diagnosis and Treatment
3.50
article

Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial

Geoffrey McCowage, Daniel Landi, Darren Hargrave, Nicholas G. Gottardo, Jordan R. Hansford, Pablo Hernáiz Driever, Peter Manley, Devorah Segal, Jung Woo Han, Sarah Leary, Lindsay Kilburn, David S. Ziegler, Evelien de Vos‐Kerkhof, Nicholas Whipple, Tim Hassall, Daniel Da Costa, Andrea T. Franson, Cassie Kline, Dong‐Anh Khuong‐Quang, Susan Chi, Nada Jabado, Michal Oren, Karsten Nysom, Sébastien Perreault, Patricia Baxter, Simon Bailey, Jiaheng Qiu, Sandya Govinda Raju, Olaf Witt
article en
8 citations

Abstract

Tovorafenib demonstrated anti-tumor activity in relapsed/refractory BRAF-altered OPG across radiological assessment criteria and was generally well tolerated. Importantly, vision remained stable or improved in most patients.

Neuro-OncologyVol. 27(5)
Royal Children's Hospital (AU), Primary Children's Hospital (US), Children's Hospital of Philadelphia (US), Children's National (US), Duke University (US), The Kids Research Institute Australia (AU), The University of Western Australia (AU), German Cancer Research Center (DE), Baylor College of Medicine (US), University of Utah (US), Heidelberg University (DE), University of Michigan (US), Sheba Medical Center (IL), Montreal Children's Hospital (CA), Severance Hospital (KR), Great Ormond Street Hospital (GB), Princess Margaret Hospital for Children (AU), University Health System (US), Women's and Children's Hospital (AU), McGill University Health Centre (CA), Cancer Institute of New South Wales (AU), University Hospital Heidelberg (DE), Centre Hospitalier Universitaire Sainte-Justine (CA), Australian Institute of Business (AU), Copenhagen University Hospital (DK), Rigshospitalet (DK), UNSW Sydney (AU), Humboldt-Universität zu Berlin (DE), NYU Langone Health (US), Children’s Health Queensland Hospital and Health Service (AU), Center for Cancer and Blood Disorders (US), National Center for Tumor Diseases (DE), Hopp Children's Cancer Center Heidelberg (DE), NGM Biopharmaceuticals (United States) (US), Sydney Children's Hospital (AU), Princess Máxima Center (NL), South Australian Health and Medical Research Institute (AU), Great North Children's Hospital (GB), Centre for Cancer Biology (AU), Texas Children's Hospital (US), Sydney Children’s Hospitals Network (AU), Children's Cancer Center (US), C. S. Mott Children's Hospital (US), Duke University Hospital (US), Yonsei University Health System (KR), Dana-Farber/Boston Children's Cancer and Blood Disorders Center (US), Perth Children's Hospital, Deutsches Konsortium für Translationale Krebsforschung (DE), University College London (GB), The University of Adelaide (AU), Université de Montréal (CA), Freie Universität Berlin (DE), Charité - Universitätsmedizin Berlin (DE), University of Pennsylvania (US), Newcastle University (GB), Philadelphia University (US)
Children's Hospital of Philadelphia, University of Pennsylvania, Texas Children's Hospital, McGill University, Deutsches Krebsforschungszentrum, Seattle Children's Research Institute, McGill University Health Centre, Children's National Hospital, National Institute for Health and Care Research, Department of Health and Social Care, Newcastle University, Cancer Institute NSW, University of New South Wales, Yonsei University, Gentofte Hospital, Great Ormond Street Hospital for Children, Rigshospitalet, Université de Montréal, Region Hovedstaden, Humboldt-Universität zu Berlin, Freie Universität Berlin, Deutschen Konsortium für Translationale Krebsforschung, Universitätsklinikum Heidelberg, Perelman School of Medicine, University of Pennsylvania, Medical School, University of Michigan, Medical Research Council, National Health and Medical Research Council, Great Ormond Street Institute of Child Health
Good health and well-being
Openalex Percentile: Top 7%
Glioma Diagnosis and Treatment
3.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.